Michael Morosky, MD
Obstetrics & Gynecology · Enfield, CTNPI 1295711638
Payments from drug & device makers
Across 18 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exact Sciences$55
- Azurity Pharmaceuticals, Inc.$39
- Astellas Pharma US Inc$33
- AMAG Pharmaceuticals, Inc.$32
- Lilly USA, LLC$28
- Actelion Pharmaceuticals US, Inc.$28
- plus $145 from 8 others
What the payments were for
- Food & beverage$32791%
- Education$329%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exact Sciences | 2 | $55 |
| Azurity Pharmaceuticals, Inc. | 2 | $39 |
| Astellas Pharma US Inc | 1 | $33 |
| AMAG Pharmaceuticals, Inc. | 2 | $32 |
| Lilly USA, LLC | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| Avion Pharmaceuticals | 2 | $26 |
| AbbVie | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Avanos Medical | 1 | $19 |
| Bayer | 1 | $17 |
| Corium, LLC | 1 | $16 |
| Merck | 1 | $12 |
| Hologic Sales And Service, LLC | 1 | $11 |
How this compares
$359 in reported general payments places this provider in the 45th percentile of 605 obstetrics & gynecology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 158 | $4,664 |
| ValacyclovirValacyclovir Hcl | 27 | $1,212 |
| Medroxyprogesterone Acetate | 53 | $1,030 |
| Terconazole | 21 | $585 |
| Famciclovir | 12 | $553 |
| Clobetasol Propionate | 15 | $537 |
| Acyclovir | 15 | $376 |
| Metronidazole | 11 | $306 |
| Fluconazole | 46 | $288 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 28 | $237 |
| Oxybutynin Chloride | 14 | $237 |
| Amitriptyline Hcl | 15 | $197 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Enfield
- Timothy MachonEnfield$22K
- Kenneth BorkowskiEnfield$5K
- Alessandro SantinNew Haven$14.1M
- Mark LeondiresNorwalk$1.4M
- Alan FineHartford$974K
- Mary MinkinNew Haven$285K
- Elena RatnerNew Haven$119K
- Frederick RauHartford$89K
- Daniel WellingManchester$63K
- Peter AuerbachGroton$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.